Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Jamaica reports deadly leptospirosis outbreak after Hurricane Melissa - 2Bowen Yang is reportedly leaving 'Saturday Night Live' after this week's episode
- 3Toddler given just 3 years to live after strange symptoms makes full recovery
- 4At least 11 killed in South Africa mass shooting
- 5Germany's Lufthansa enters race for stake in Portuguese airline TAP
- US EPA will reassess safety of herbicide paraquat, says its chief
- Women take pride in Holy Week roles after a Spanish Catholic brotherhood's procession excluded them
- Clocks to go forward one hour in Europe as summer time starts
- When darkness shines: How dark stars could illuminate the early universe
- Arctic sea ice hits lowest winter level as unprecedented heat hits smashes records all over Earth
- At least 55 injured in Russia after train crashes, overturns
- Taste the World: Five Food sources That Have Dazzled Worldwide Palates
- 5 Affordable Travel Destinations To Visit In South America
- Hezbollah sees potential win as Israel backs down from disarmament goal
